SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001328143-20-000050
Filing Date
2020-11-05
Accepted
2020-11-05 16:01:41
Documents
60
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adms-20200930.htm   iXBRL 10-Q 1375512
2 EX-10.1 adms10qq32020ex101.htm EX-10.1 12377
3 EX-10.2 adms10qq32020ex102.htm EX-10.2 266959
4 EX-31.1 adms10qq32020ex311.htm EX-31.1 14118
5 EX-31.2 adms10qq32020ex312.htm EX-31.2 14518
6 EX-32.1 adms10qq32020ex321.htm EX-32.1 11111
12 image81.jpg GRAPHIC 3293
  Complete submission text file 0001328143-20-000050.txt   5641806

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adms-20200930.xsd EX-101.SCH 30273
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adms-20200930_cal.xml EX-101.CAL 62012
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adms-20200930_def.xml EX-101.DEF 179208
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adms-20200930_lab.xml EX-101.LAB 433324
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adms-20200930_pre.xml EX-101.PRE 275778
13 EXTRACTED XBRL INSTANCE DOCUMENT adms-20200930_htm.xml XML 835069
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36399 | Film No.: 201290313
SIC: 2834 Pharmaceutical Preparations